Cargando…

A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C

BACKGROUND: Safe, highly curative, short course, direct acting antiviral (DAA) therapies are now available to treat chronic hepatitis C. DAA therapy is freely available to all adults chronically infected with the hepatitis C virus (HCV) in Australia. If left untreated, hepatitis C may lead to progre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramsay, Jessica, Marsh, Julie, Pedrana, Alisa, Andric, Nada, Norman, Richard, Cheng, Wendy, Webb, Steve, Zeps, Nikolajs, Bellgard, Matthew, Graves, Todd, Hellard, Margaret, Snelling, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596998/ https://www.ncbi.nlm.nih.gov/pubmed/33121439 http://dx.doi.org/10.1186/s12879-020-05531-4

Ejemplares similares

Affordable treatment and political commitment are crucial to eliminate hepatitis C globally
por: Hellard, Margaret, et al.
Publicado: (2021)

Pathways to ensure universal and affordable access to hepatitis C treatment
por: Douglass, Caitlin H., et al.
Publicado: (2018)

Letter to the Editor: Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective
por: Harney, Brendan, et al.
Publicado: (2020)

Australia needs to increase testing to achieve hepatitis C elimination
por: Scott, Nick, et al.
Publicado: (2020)

Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
por: Scott, Nick, et al.
Publicado: (2018)

Hepatitis C risk perceptions and attitudes towards reinfection among HIV‐diagnosed gay and bisexual men in Melbourne, Australia
por: Schroeder, Sophia E, et al.
Publicado: (2019)

Does the registry speak your language? A case study of the Global Angelman Syndrome Registry
por: Tones, Megan, et al.
Publicado: (2023)

Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model
por: Bellgard, Matthew I., et al.
Publicado: (2018)

Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019
por: Lee Wilkinson, Anna, et al.
Publicado: (2021)

Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 – CORRIGENDUM
por: Lee Wilkinson, Anna, et al.
Publicado: (2022)

Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients
por: Draper, Bridget, et al.
Publicado: (2022)

The case for a universal hepatitis C vaccine to achieve hepatitis C elimination
por: Scott, Nick, et al.
Publicado: (2019)

Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study
por: Yee, Win Lei, et al.
Publicado: (2023)

Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
por: Draper, Bridget Louise, et al.
Publicado: (2022)

High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
por: Sacks-Davis, Rachel, et al.
Publicado: (2013)

Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study
por: Draper, Bridget Louise, et al.
Publicado: (2020)

Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings: a mixed-methods evaluation of the Tasmanian Eliminate Hepatitis C Australia Outreach Project, 2020–2022
por: Dawe, Joshua, et al.
Publicado: (2023)

Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study
por: Scott, Dr Nick, et al.
Publicado: (2021)

The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia
por: Gunn, Jack, et al.
Publicado: (2023)

Methodological challenges in appraising evidence on diagnostic testing for WHO guidelines on hepatitis B and hepatitis C virus infection
por: Chou, Roger, et al.
Publicado: (2017)

A systematic review of community based hepatitis C treatment
por: Wade, Amanda J., et al.
Publicado: (2016)

WHO guidelines on testing for hepatitis B and C – meeting targets for testing
por: Hellard, Margaret E., et al.
Publicado: (2017)

Outcomes of the CT2 study: A ‘one‐stop‐shop’ for community‐based hepatitis C testing and treatment in Yangon, Myanmar
por: Draper, Bridget Louise, et al.
Publicado: (2021)

Impact of COVID‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs
por: Traeger, Michael W., et al.
Publicado: (2022)

The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services
por: Traeger, Michael W., et al.
Publicado: (2020)

Annual Registry for Hepatitis C and Hepatitis B is Needed for Predicting the Burden of Hepatocellolar Carcinoma in Iran
por: Fazeli, Zeinab, et al.
Publicado: (2013)

Achieving a hepatitis C cure: a qualitative exploration of the experiences and meanings of achieving a hepatitis C cure using the direct acting antivirals in Australia
por: Richmond, Jacqueline A., et al.
Publicado: (2018)

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)
por: Schlevogt, Bernhard, et al.
Publicado: (2021)

Real‐world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)
por: Krüger, Kathrin, et al.
Publicado: (2022)

Hepatitis C elimination in people living with HIV – the importance of biomedical and behavioural interventions
por: van Santen, Daniela K, et al.
Publicado: (2020)

Hepatitis "C" /
por: Domínguez Pérez, Eva
Publicado: (1993)

Chasing the immortal strand: evidence for nature's way of protecting the breast genome
por: Zeps, Nikolajs, et al.
Publicado: (2011)

Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis
por: Aliannejad, Rasoul, et al.
Publicado: (2011)

Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
por: Higgs, Peter, et al.
Publicado: (2011)

Eradication of hepatitis C infection: The importance of targeting people who inject drugs
por: Hellard, Margaret, et al.
Publicado: (2014)

Hepatitis C Virus in the Hematology/Oncology Patient
por: Vogel, Wendy H.
Publicado: (2017)

Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions
por: Wallace, Jack, et al.
Publicado: (2022)

The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service
por: Wade, Amanda J., et al.
Publicado: (2015)

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry
por: Tacke, Frank, et al.
Publicado: (2022)

Advancement in the Development of Models for Hepatitis C Research
por: Carcamo, Wendy C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_el19sk97bugkp3uhbsim3e5i5a